A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.
Cetuximab performs better than durvalumab in treating head and neck cancers
Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report. Smokers and drinkers, as well